Chargement en cours...
In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.
In vitro activity of LB20304 against 1,231 clinical isolates was evaluated and compared with those of ciprofloxacin, sparfloxacin, lomefloxacin, and ofloxacin. LB20304 demonstrated the most potent activity against gram-positive bacteria. It was 32- to 64-fold more active than ciprofloxacin against m...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1996
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC163372/ https://ncbi.nlm.nih.gov/pubmed/8726042 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|